# Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

> **NCT05120284** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 40 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Dichloroacetate (DCA)
- **GENETIC:** Genotype

## Key facts

- **NCT ID:** NCT05120284
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05120284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05120284, "Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05120284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*